News

On September 22nd and 23rd two members of the Amyloidosis Research Consortium were invited speakers at the Global Genes 5th Annual RARE Patient Advocacy Summit event in Huntington Beach, California. ARC CEO Isabelle Lousada delivered a presentation on The Patient's Role in...

ARC is supporting a Satellite Symposium at the Heart Failure Society of America (HFSA) Meeting, 4-6pm, September 17, 2016. Cardiologists miss the diagnosis of amyloidosis more frequently than any other discipline. Don't be one of them. Join ARC for an...

Amyloidosis Research Consortium Announces Publication of Seminal Manuscript in Peer-Reviewed Journal Leukemia Encouraging Use of NT-proBNP as Endpoint in Clinical Trials. International AL amyloidosis expert community agrees N-terminal pro-brain natriuretic peptide (NT-proBNP) is analytically validated and clinically qualified to be...

The 2016 International Symposium on Amyloidosis was held in Uppsala, Sweden in early July. Over the years the meeting has grown in size and it was impressive to see over 400 scientists and experts come together to spend three days...

“Save one life and you’re a hero, save one hundred lives and you’re a nurse.” This anonymous quote highlights the important role of nurses in the medical profession. With this in mind, ARC participated in the American Association of Heart...